J

Jayamas Medica Industri TBK PT
IDX:OMED

Watchlist Manager
Jayamas Medica Industri TBK PT
IDX:OMED
Watchlist
Price: 178 IDR -1.11% Market Closed
Market Cap: 4.8T IDR
Have any thoughts about
Jayamas Medica Industri TBK PT?
Write Note

Intrinsic Value

The intrinsic value of one OMED stock under the Base Case scenario is 177.56 IDR. Compared to the current market price of 178 IDR, Jayamas Medica Industri TBK PT is Fairly Valued.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OMED Intrinsic Value
177.56 IDR
Fairly Valued
Intrinsic Value
Price
J
Worst Case
Base Case
Best Case

Valuation Backtest
Jayamas Medica Industri TBK PT

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for OMED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about OMED?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Jayamas Medica Industri TBK PT

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Jayamas Medica Industri TBK PT

Provide an overview of the primary business activities
of Jayamas Medica Industri TBK PT.

What unique competitive advantages
does Jayamas Medica Industri TBK PT hold over its rivals?

What risks and challenges
does Jayamas Medica Industri TBK PT face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Jayamas Medica Industri TBK PT.

Provide P/S
for Jayamas Medica Industri TBK PT.

Provide P/E
for Jayamas Medica Industri TBK PT.

Provide P/OCF
for Jayamas Medica Industri TBK PT.

Provide P/FCFE
for Jayamas Medica Industri TBK PT.

Provide P/B
for Jayamas Medica Industri TBK PT.

Provide EV/S
for Jayamas Medica Industri TBK PT.

Provide EV/GP
for Jayamas Medica Industri TBK PT.

Provide EV/EBITDA
for Jayamas Medica Industri TBK PT.

Provide EV/EBIT
for Jayamas Medica Industri TBK PT.

Provide EV/OCF
for Jayamas Medica Industri TBK PT.

Provide EV/FCFF
for Jayamas Medica Industri TBK PT.

Provide EV/IC
for Jayamas Medica Industri TBK PT.

Show me price targets
for Jayamas Medica Industri TBK PT made by professional analysts.

What are the Revenue projections
for Jayamas Medica Industri TBK PT?

How accurate were the past Revenue estimates
for Jayamas Medica Industri TBK PT?

What are the Net Income projections
for Jayamas Medica Industri TBK PT?

How accurate were the past Net Income estimates
for Jayamas Medica Industri TBK PT?

What are the EPS projections
for Jayamas Medica Industri TBK PT?

How accurate were the past EPS estimates
for Jayamas Medica Industri TBK PT?

What are the EBIT projections
for Jayamas Medica Industri TBK PT?

How accurate were the past EBIT estimates
for Jayamas Medica Industri TBK PT?

Compare the revenue forecasts
for Jayamas Medica Industri TBK PT with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Jayamas Medica Industri TBK PT and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Jayamas Medica Industri TBK PT against its competitors.

Analyze the profit margins
(gross, operating, and net) of Jayamas Medica Industri TBK PT compared to its peers.

Compare the P/E ratios
of Jayamas Medica Industri TBK PT against its peers.

Discuss the investment returns and shareholder value creation
comparing Jayamas Medica Industri TBK PT with its peers.

Analyze the financial leverage
of Jayamas Medica Industri TBK PT compared to its main competitors.

Show all profitability ratios
for Jayamas Medica Industri TBK PT.

Provide ROE
for Jayamas Medica Industri TBK PT.

Provide ROA
for Jayamas Medica Industri TBK PT.

Provide ROIC
for Jayamas Medica Industri TBK PT.

Provide ROCE
for Jayamas Medica Industri TBK PT.

Provide Gross Margin
for Jayamas Medica Industri TBK PT.

Provide Operating Margin
for Jayamas Medica Industri TBK PT.

Provide Net Margin
for Jayamas Medica Industri TBK PT.

Provide FCF Margin
for Jayamas Medica Industri TBK PT.

Show all solvency ratios
for Jayamas Medica Industri TBK PT.

Provide D/E Ratio
for Jayamas Medica Industri TBK PT.

Provide D/A Ratio
for Jayamas Medica Industri TBK PT.

Provide Interest Coverage Ratio
for Jayamas Medica Industri TBK PT.

Provide Altman Z-Score Ratio
for Jayamas Medica Industri TBK PT.

Provide Quick Ratio
for Jayamas Medica Industri TBK PT.

Provide Current Ratio
for Jayamas Medica Industri TBK PT.

Provide Cash Ratio
for Jayamas Medica Industri TBK PT.

What is the historical Revenue growth
over the last 5 years for Jayamas Medica Industri TBK PT?

What is the historical Net Income growth
over the last 5 years for Jayamas Medica Industri TBK PT?

What is the current Free Cash Flow
of Jayamas Medica Industri TBK PT?

Discuss the annual earnings per share (EPS)
trend over the past five years for Jayamas Medica Industri TBK PT.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Jayamas Medica Industri TBK PT

Balance Sheet Decomposition
Jayamas Medica Industri TBK PT

Current Assets 2.2T
Cash & Short-Term Investments 1.2T
Receivables 281.6B
Other Current Assets 696.9B
Non-Current Assets 519.6B
Long-Term Investments 59.8B
PP&E 445.4B
Intangibles 130.4m
Other Non-Current Assets 14.2B
Current Liabilities 307.5B
Accounts Payable 96.7B
Accrued Liabilities 12.9B
Other Current Liabilities 197.9B
Non-Current Liabilities 81.7B
Long-Term Debt 17B
Other Non-Current Liabilities 64.7B
Efficiency

Earnings Waterfall
Jayamas Medica Industri TBK PT

Revenue
1.8T IDR
Cost of Revenue
-1.2T IDR
Gross Profit
599.3B IDR
Operating Expenses
-284.5B IDR
Operating Income
314.8B IDR
Other Expenses
-26.9B IDR
Net Income
287.9B IDR

Free Cash Flow Analysis
Jayamas Medica Industri TBK PT

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

OMED Profitability Score
Profitability Due Diligence

Jayamas Medica Industri TBK PT's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive 3-Year Average ROE
Positive Operating Income
57/100
Profitability
Score

Jayamas Medica Industri TBK PT's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

OMED Solvency Score
Solvency Due Diligence

Jayamas Medica Industri TBK PT's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Jayamas Medica Industri TBK PT's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OMED Price Targets Summary
Jayamas Medica Industri TBK PT

Wall Street analysts forecast OMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OMED is 287.64 IDR with a low forecast of 284.82 IDR and a high forecast of 296.1 IDR.

Lowest
Price Target
284.82 IDR
60% Upside
Average
Price Target
287.64 IDR
62% Upside
Highest
Price Target
296.1 IDR
66% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for OMED?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for OMED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Jayamas Medica Industri TBK PT

Country

Indonesia

Industry

Health Care

Market Cap

4.8T IDR

Dividend Yield

1.62%

Description

PT Jayamas Medica Industri engages in the manufacture, wholesale, and retail trade of medical devices. The firm's segments include Manufacturing, Distribution, and Retail. The Manufacturing segment is involved in the manufacture of medical supplies and equipment. The Distribution segment is involved with the large-scale distribution of medical supplies and equipment at strategic locations. The Retail segment is involved with the retail of medical supplies and equipment through Medicom stores and online platforms. Its products category includes medical disposables and consumables, antiseptic and dialysis, diagnostics and equipment's, walking aids and rehabilitation care, biotechnology and laboratory, and hospital furniture's. Its One Med store offers various products, such as blood check tool, wash glove, wound care instruments, nebulizer, mask, skin marker, therapeutic and massage tools, cotton swab, and electro medicine accessories, among others.

Contact

JAWA TIMUR
By Pass Krian Km 28 Ds. Sidomojo, Krian Jawa Timur
+62318982349
onemed.co.id

IPO

2022-11-08

Employees

1 163

Officers

President Director
Dr. Herlien Sri Ariani
Director of Finance & Director
Mr. Eka Suwignyoo
Director of Operations & Director
Mr. Leonard Hariadi Hartanto
Marketing & Sales Director and Director
Mr. Louis Krisnadi Hartanto
Corporate Secretary
Mr. Daniel Kurniawan

See Also

Discover More
What is the Intrinsic Value of one OMED stock?

The intrinsic value of one OMED stock under the Base Case scenario is 177.56 IDR.

Is OMED stock undervalued or overvalued?

Compared to the current market price of 178 IDR, Jayamas Medica Industri TBK PT is Fairly Valued.

Back to Top